INTERCEPT
Live / Applied — Response to non-final action entered (as of 06 Nov 2025)
What this means for you
Not registered yet, but its 07 Mar 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99073125
- Mark type
- Stylized text
- Filed
- 07 Mar 2025
- Attorney of record
- Nate A. Garhart
Goods and services
- Class 005 — Pharmaceuticals: Blood products, namely, platelets, plasma, red blood cells, cryoprecipitate and fibrinogen complex for medical purposes; pathogen inactivated blood for medical purposes; pathogen inactivated blood products, namely, platelets, plasma, red blood cells, cryoprecipitated plasma and fibrinogen complex for medical purposes; pathogen reduced blood products, namely, platelets, plasma, red blood cells, cryoprecipitate and fibrinogen complex for medical purposes.
Owner
- Cerus Corporation, Concord, CA, US
Prosecution history
- 06 Nov 2025 — AMENDMENT TO USE PROCESSING COMPLETE
- 06 Nov 2025 — USE AMENDMENT FILED
- 06 Nov 2025 — TEAS AMENDMENT OF USE RECEIVED
- 06 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Aug 2025 — NON-FINAL ACTION E-MAILED
- 09 Aug 2025 — NON-FINAL ACTION WRITTEN
- 09 Aug 2025 — ASSIGNED TO EXAMINER
- 07 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 07 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED